Provided by Tiger Trade Technology Pte. Ltd.

Vanguard Health Care ETF

313.30
-1.3100-0.42%
Pre-market: 312.16-1.1433-0.36%04:00 EDT
Volume:194.42K
Turnover:61.00M
Market Cap:18.85B
PE:34.01
High:314.92
Open:314.92
Low:312.93
Close:314.61
52wk High:330.75
52wk Low:249.57
Shares:60.18M
Float Shares:60.18M
Volume Ratio:0.97
T/O Rate:0.32%
Dividend:4.73
Dividend Rate:1.51%
EPS(TTM):9.21
EPS(LYR):41.51
ROE:3.75%
ROA:0.89%
PB:0.95
PE(LYR):7.55

Loading ...

HSBC Adjusts Price Target on Eli Lilly and Co. to $940 From $850, Keeps Reduce Rating

MT Newswires Live
·
1 hour ago

Private Equity Firm TPG Explores Sale of Healthcare Software Company Lyric, Potential Valuation at $5 Billion

Stock News
·
8 hours ago

TPG weighs roughly $5B sale of Lyric, Reuters reports

TIPRANKS
·
14 hours ago

'Cut Points' for 2027 Medicare Advantage Plans Look Neutral to Positive, Analysts Say

Reuters
·
15 hours ago

Exchange-Traded Funds, US Equities Fall After Midday

MT Newswires Live
·
17 hours ago

Sector Update: Healthcare

MT Newswires Live
·
17 hours ago

Merck Price Target Raised to $161.00/Share from $127.00 by Leerink Partners

Dow Jones
·
18 hours ago

SHL Telemedicine Tightens Grip on Israeli Medical Centers With Mediton and Medishur Buyout

TIPRANKS
·
18 hours ago

Top Midday Stories: Meta Launches Muse Personal AI Agent; Dow Said to Consider Exiting $20 Billion Chemicals JV With Saudi Aramco

MT Newswires Live
·
Yesterday

UnitedHealth Falls; Cites Pressure in Commercial Business

Reuters
·
Yesterday

Tyra Biosciences Stock Plunges 22% as Bladder Cancer Pill Fails to Impress

Dow Jones
·
Yesterday

Abbvie Exec Says Strong Balance Sheet and Long Growth Runway Allow Company to Consider Both Early- and Late-Stage Business Development Opportunities - Conf Call

THOMSON REUTERS
·
Yesterday

Abbvie Exec Says Expects Approval of Subcutaneous Crohn's Disease Treatment in Q4 - Conf Call

THOMSON REUTERS
·
Yesterday

UnitedHealth Shares Down 5.2%

THOMSON REUTERS
·
Yesterday

UnitedHealth, Alphabet Inc. Cl a Share Losses Lead Dow's 350-Point Drop

Dow Jones
·
Yesterday

PRF Technologies Spins Out GridFeed Unit to Drive AI Renewable Energy Trading Partnerships

TIPRANKS
·
Yesterday

LifeStance Health Group Announces Launch of Secondary Public Offering

GlobeNewswire
·
Yesterday

Leerink Partners Adjusts Price Target on Merck & Co. to $161 From $127, Keeps Outperform Rating

MT Newswires Live
·
Yesterday

Merck & Co Inc : Leerink Partners Raises Target Price to $161 from $127

THOMSON REUTERS
·
Yesterday

Merck price target raised to $161 from $127 at Leerink

TIPRANKS
·
Yesterday